NASDAQ$WBA
Walgreens Boots Alliance Inc · Q2 2022 earnings
Q2 2022 earnings · · Investor relations
Briefing
Walgreens reported strong Q2 2022 results with increased sales and earnings, driven by COVID-19 vaccinations and testing, U.S. retail comparable sales, and Boots UK retail comparable sales.
Walgreens Boots Alliance reported a 3.0% increase in sales from continuing operations to $33.8 billion and an adjusted EPS increase of 25.9% to $1.59 in the second quarter of fiscal 2022. The company is maintaining its full-year adjusted EPS guidance of low-single digit growth.
- Second quarter EPS from continuing operations was $1.02, while adjusted EPS increased 25.9 percent to $1.59.
- Second quarter sales from continuing operations increased 3.0 percent to $33.8 billion.
- Second quarter operating income from continuing operations increased to $1.2 billion.
- Walgreens Health pro forma sales up 128 percent compared to year-ago standalone results.
Headline financials
Revenue & EPS history
Walgreens · Revenue · Quarterly
$33.8B
Revenue by segment
Walgreens · $33.8B total across 3 segments · Q2 2022
- U.S. Pharmacy$27.7B—81.9%
- International$5.6B—16.6%
- U.S. Healthcare$527M—1.6%
Forward guidance
Maintaining full year adjusted EPS guidance of low-single digit growth
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 16 quarterly earnings reports · overlaid with Q2 2022
-0.1%
Avg return
Earnings day
+0.4%
Avg return
5 days after
-1.9%
Avg return
30 days after
53%
33 / 62 earnings
Positive
+29.1%
Q1 2025
Best reaction
-22.7%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | — | — | — | |
| Q3 2025 | +0.4% | +1.5% | +2.7% | |
| Q2 2025 | -1.1% | +0.5% | +4.1% | |
| Q1 2025 | +29.1% | +36.1% | +10.0% | |
| Q4 2024 | +23.0% | +18.7% | -2.0% | |
| Q3 2024 | -22.7% | -26.0% | -24.5% | |
| Q2 2024 | -7.0% | -10.9% | -15.7% | |
| Q1 2024 | -2.2% | -0.6% | -11.4% | |
| Q4 2023 | +2.9% | +2.1% | -7.3% | |
| Q3 2023 | -7.9% | -10.2% | -3.0% | |
| Q2 2023 | +3.7% | +5.0% | +6.6% | |
| Q1 2023 | -2.3% | -2.1% | -1.1% | |
| Q4 2022 | +4.1% | +3.8% | +29.4% | |
| Q3 2022 | -5.7% | -5.7% | -2.9% | |
| Q2 2022 | -7.6% | -8.4% | -10.6% | |
| Q1 2022 | -0.3% | +0.6% | -10.0% | |
| Q4 2021 | +3.5% | +1.5% | +4.8% | |
| Q3 2021 | -8.4% | — | — | |
| Q2 2021 | +3.3% | — | — | |
| Q1 2021 | +5.1% | — | — | |
| Q4 2020 | +4.2% | — | — | |
| Q3 2020 | -5.1% | — | — | |
| Q2 2020 | -5.4% | — | — | |
| Q1 2020 | -7.8% | — | — | |
| Q4 2019 | +1.5% | — | — | |
| Q3 2019 | +4.4% | — | — | |
| Q2 2019 | -13.6% | — | — | |
| Q1 2019 | -8.2% | — | — | |
| Q4 2018 | +1.6% | — | — | |
| Q3 2018 | -9.4% | — | — | |
| Q2 2018 | -0.7% | — | — | |
| Q1 2018 | -3.4% | — | — | |
| Q4 2017 | -0.3% | — | — | |
| Q3 2017 | +1.6% | — | — | |
| Q2 2017 | -1.0% | — | — | |
| Q1 2017 | +0.1% | — | — | |
| Q4 2016 | +5.7% | — | — | |
| Q3 2016 | -3.6% | — | — | |
| Q2 2016 | -3.0% | — | — | |
| Q1 2016 | +1.8% | — | — | |
| Q4 2015 | -11.9% | — | — | |
| Q3 2015 | +8.4% | — | — | |
| Q1 2014 | +4.9% | — | — | |
| Q2 2015 | +4.9% | — | — | |
| Q4 2013 | +4.9% | — | — | |
| Q1 2015 | +3.2% | — | — | |
| Q4 2014 | -0.9% | — | — | |
| Q3 2014 | +0.6% | — | — | |
| Q2 2014 | +1.0% | — | — | |
| Q3 2013 | -1.0% | — | — | |
| Q2 2013 | +0.4% | — | — | |
| Q1 2013 | +1.6% | — | — | |
| Q4 2012 | +1.4% | — | — | |
| Q3 2012 | -3.2% | — | — | |
| Q2 2012 | -1.9% | — | — | |
| Q1 2012 | +4.1% | — | — | |
| Q4 2011 | +0.4% | — | — | |
| Q3 2011 | -0.9% | — | — | |
| Q2 2011 | +1.8% | — | — | |
| Q1 2010 | +2.5% | — | — | |
| Q4 2010 | +1.8% | — | — | |
| Q3 2010 | -0.1% | — | — | |
| Q2 2009 | +0.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro